| 000 | 03837nam a22003738i 4500 | ||
|---|---|---|---|
| 001 | CR9780511527098 | ||
| 003 | UkCbUP | ||
| 005 | 20200124160244.0 | ||
| 006 | m|||||o||d|||||||| | ||
| 007 | cr|||||||||||| | ||
| 008 | 090407s2000||||enk o ||1 0|eng|d | ||
| 020 | _a9780511527098 (ebook) | ||
| 020 | _z9780521622639 (hardback) | ||
| 040 |
_aUkCbUP _beng _erda _cUkCbUP |
||
| 050 | 0 | 0 |
_aRC271.I45 _bC365 2000 |
| 082 | 0 | 0 |
_a616.99/406 _221 |
| 245 | 0 | 0 |
_aCancer vaccines and immunotherapy / _cedited by Peter L. Stern, Peter C.L. Beverley, and Miles W. Carroll. |
| 246 | 3 | _aCancer Vaccines & Immunotherapy | |
| 264 | 1 |
_aCambridge : _bCambridge University Press, _c2000. |
|
| 300 |
_a1 online resource (x, 286 pages) : _bdigital, PDF file(s). |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aTitle from publisher's bibliographic system (viewed on 05 Oct 2015). | ||
| 505 | 0 | 0 |
_tImmunity and cancer / _rPeter C.L. Beverley, Miles W. Carroll, Peter L. Sterm -- _tImmunotherapy of bladder cancer / _rAnton B. Alexandroff, Keith James -- _tPoxviruses as vectors for cancer immunotherapy / _rMiles W. Carroll, Nicholas P. Restifo -- _tVaccinia-based human papillomavirus vaccines in cervical cancer / _rLeszek K. Borysiewicz, Stephen Man -- _tVaccine delivery and immunosuppression in cervical cancer / _rMichael P. Rudolf, Laurie A. Small, Markwin P. Velders, Diane M. DaSilva, Sanne Weijzen, W. Martin Kast -- _tVaccines for colon cancer / _rHoward L. Kaufman, Jeffrey Schlom -- _tMUC1 vaccines and breast cancer / _rJoyce Taylor-Papadimitriou, Joy Burchell, David W. Miles -- _tAnti-idiotypic vaccination / _rLindy G. Durrant, Ian Spendlove, R. Adrian Robins -- _tImmunotherapy and vaccination against Epstein-Barr virus-associated cancer / _rJohn R. Arrand -- _tSerologically identified tumour antigens as cancer vaccines / _rUgur Sahin, Ozlem Tureci, Michael Pfreundschuh -- _tCTL-defined cancer vaccines in melanoma and other epithelial cancers / _rElke Jager, Dirk Jager, Alexander Knuth -- _tDNA vaccines against B-cell tumours / _rFreda K. Stevenson, Delin Zhu, Myfanwy Spellerberg, Catherine A. King, Surinder S. Sahota, Jason Rice, Andrew R. Thompsett, Terry J. Hamblin -- _tDendritic cell approaches to immunotherapy / _rMalcolm Adams, Bharat Jasani, Camilo A.L.S. Colaco, Malcolm D. Mason -- _tOverview / _rPeter L. Stern, Peter C.L. Beverley, Miles W. Carroll -- _tRecent developments / _rPeter L. Stern. |
| 520 | _aRapid progress in the definition of tumour antigens, and improved immunisation methods, bring effective cancer vaccines within reach. In this wide-ranging survey, clinicians and scientists at the forefront of these developments review therapeutic cancer vaccine strategies against a variety of diseases and molecular targets. Intended for an interdisciplinary readership, chapters cover the rationale, development and implementation of vaccines in human cancers generally, and with specific reference to cancer of the cervix, breast, colon, bladder, and prostate, and to melanoma and lymphoma. Target identification, delivery vectors and clinical trial design are reviewed, and the book begins and ends with lucid overviews from the editors, including the most recent developments. Encapsulating recent scientific progress and the likely clinical potential of cancer vaccines, this book provides an essential introduction and guide for oncologists, immunologists and indeed all clinicians treating cancer patients. | ||
| 650 | 0 | _aCancer vaccines. | |
| 650 | 0 |
_aCancer _xImmunotherapy. |
|
| 700 | 1 |
_aStern, Peter L., _eeditor. |
|
| 700 | 1 |
_aBeverley, Peter C. L., _eeditor. |
|
| 700 | 1 |
_aCarroll, Miles W. _q(Miles William), _d1965- _eeditor. |
|
| 776 | 0 | 8 |
_iPrint version: _z9780521622639 |
| 856 | 4 | 0 | _uhttps://doi.org/10.1017/CBO9780511527098 |
| 999 |
_c518862 _d518860 |
||